5 studies found for:    parkinson's a2a
Show Display Options
Rank Status Study
1 Recruiting Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.
Conditions: Parkinson Disease;   Huntington Disease
Intervention: Drug: [123I]MNI-420
2 Completed KW-6002 to Treat Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: KW-6002;   Drug: IV Levodopa
3 Completed A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Study P04938)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Placebo for Preladenant;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo for Rasagiline 1 mg capsule
4 Completed Study to Evaluate SYN115 in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Placebo;   Drug: Tozadenant
5 Terminated A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (P05664 AM5)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo for Rasagiline 1 mg capsule;   Drug: Placebo for Preladenant

Indicates status has not been verified in more than two years